Conference Call
Thursday, September 18, 2014
Noon Eastern, 9am Pacific
1-866-740-1260 x5273160 (required for audio)
http://www.readytalk.com/?ac=5273160
For call materials: http://tinyurl.com/biosense20
· Roll call· Approval of Notes
· Reprise of our conclusions from the May 28 in-person BGG meeting (link to notes): (Joe)
Action Items for long-term success:
o Improve communication between user community, Governance Group, and CDC
o Continued CDC support of jurisdictional capacity to perform Syndromic Surveillance
o Improvement of analytic capabilities in the cloud environment
o Improved documentation of BioSense algorithms to improve trust in alert detection
· General CDC updates (CDC, Mike, Paula, etc)
· In-person meeting
· Users Group update (Stacey)
· User Workgroups Update
o Onboarding (German)
o Data Quality (Stacey)
o Data Sharing (Jim)
o Syndrome Definitions (Julie)
· Statement regarding the role of Governance group regarding community issues or platform issues (Joe)
“The BioSense Gov. Group (BGG) represents the SyS Platform stakeholder community. Before seeking input about the SyS Platform from the user community, the CDC should collaborate with the BGG to determine an appropriate way to collect that input.
Process: When contacted by the CDC, the Chair or past-chair can decide whether or not the full BGG needs to be contacted to allow for comment; the chair or past-chair will always inform the BGG about those decisions at the next BGG meeting. Issues that concern the general syndromic surveillance community do not need to be run by the BGG first, though the BGG should be included in communications to the whole community. If the CDC has any question on how best or whether to interact with the general syndromic surveillance community on a particular issue, the BGG is always available to assist on the best approach.”
· Governance Workgroups:
o Onboarding: Process and Quality (Requested to fold into User Workgroup) (Workgroup member)
o Assure representative set of jurisdictions are onboarded (Joe/Atar)
o Understand why available HIEs are sometimes not used (Bryant)
o Define 3 use cases for BioSense data sharing (Request to disband) (Jim/Joe)
· How should we organize surveillance for arising syndromes (MERS, HEV68) (Joe)
Meeting Agenda 2